(+)-dexrazoxane multiple interactions ISO RGD:731285 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of HSD17B4 mRNA CTD PMID:26873546 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HSD17B4 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:731285 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSD17B4 mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:731285 6480464 1, 2-Dimethylhydrazine results in decreased expression of HSD17B4 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:731285 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HSD17B4 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:731284 6480464 Dinitrochlorobenzene binds to HSD17B4 protein CTD PMID:32991956 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of HSD17B4 mRNA CTD PMID:17108234 17beta-estradiol affects metabolic processing ISO RGD:731284 6480464 HSD17B4 protein affects the metabolism of Estradiol CTD PMID:16054388 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of HSD17B4 mRNA CTD PMID:26496021 17beta-estradiol increases chemical synthesis ISO RGD:731284 6480464 HSD17B4 protein results in increased chemical synthesis of Estradiol CTD PMID:16054388 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:731284 6480464 Metribolone promotes the reaction [NDRG1 protein binds to HSD17B4 protein] CTD PMID:17220478 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:731284 6480464 2 more ... CTD PMID:18248924 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:731285 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:731284 6480464 2 more ... CTD PMID:18248924 2,3,7,8-tetrabromodibenzodioxine decreases expression ISO RGD:731284 6480464 2 more ... CTD PMID:17447562 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSD17B4 mRNA CTD PMID:21215274 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731285 6480464 Tetrachlorodibenzodioxin affects the expression of HSD17B4 mRNA CTD PMID:21570461 , PMID:36222588 2,4,6-trichlorophenol decreases expression ISO RGD:731284 6480464 2 more ... CTD PMID:21296122 2,4-diaminotoluene increases expression ISO RGD:731285 6480464 2, 4-diaminotoluene results in increased expression of HSD17B4 mRNA CTD PMID:22016648 2,4-dibromophenol increases expression ISO RGD:731284 6480464 2, 4-dibromophenol results in increased expression of HSD17B4 mRNA CTD PMID:17447562 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of HSD17B4 mRNA CTD PMID:21346803 2,6-dibromophenol decreases expression ISO RGD:731284 6480464 2, 6-dibromophenol results in decreased expression of HSD17B4 mRNA CTD PMID:17447562 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of HSD17B4 mRNA CTD PMID:21346803 2-bromophenol increases expression ISO RGD:731284 6480464 2-bromophenol results in increased expression of HSD17B4 mRNA CTD PMID:17447562 2-methylcholine affects expression ISO RGD:731284 6480464 beta-methylcholine affects the expression of HSD17B4 mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of HSD17B4 mRNA CTD PMID:26988606 3,4-dihydrocoumarin increases expression ISO RGD:731285 6480464 3, 4-dihydrocoumarin results in increased expression of HSD17B4 mRNA CTD PMID:22016648 4,4'-diaminodiphenylmethane increases expression ISO RGD:731285 6480464 4, 4'-diaminodiphenylmethane results in increased expression of HSD17B4 mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of HSD17B4 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO RGD:731284 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of HSD17B4 protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSD17B4 mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide decreases expression ISO RGD:731285 6480464 Fenretinide results in decreased expression of HSD17B4 mRNA CTD PMID:28973697 4-nitro-m-cresol multiple interactions ISO RGD:731284 6480464 [4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD17B4 protein CTD PMID:18336853 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of HSD17B4 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of HSD17B4 mRNA CTD PMID:19483382 7-ketocholesterol decreases expression ISO RGD:731285 6480464 7-ketocholesterol results in decreased expression of HSD17B4 mRNA CTD PMID:29065513 8-Br-cAMP multiple interactions ISO RGD:731284 6480464 [4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD17B4 protein CTD PMID:18336853 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of HSD17B4 mRNA CTD PMID:31881176 aconitine increases expression EXP 6480464 Aconitine results in increased expression of HSD17B4 protein CTD PMID:33236894 acrolein multiple interactions ISO RGD:731284 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of HSD17B4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of HSD17B4 mRNA CTD PMID:32699268 aflatoxin B1 decreases methylation ISO RGD:731284 6480464 Aflatoxin B1 results in decreased methylation of HSD17B4 gene CTD PMID:27153756 alpha-pinene multiple interactions ISO RGD:731284 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of HSD17B4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of HSD17B4 mRNA CTD PMID:32699268 aminoglutethimide decreases expression ISO RGD:731284 6480464 Aminoglutethimide results in decreased expression of HSD17B4 mRNA CTD PMID:16935330 aminoglutethimide multiple interactions ISO RGD:731284 6480464 Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of HSD17B4 mRNA] CTD PMID:16935330 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of HSD17B4 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HSD17B4 mRNA CTD PMID:16483693 androst-5-ene-3beta,17beta-diol affects metabolic processing ISO RGD:731284 6480464 HSD17B4 protein affects the metabolism of Androstenediol CTD PMID:16054388 androst-5-ene-3beta,17beta-diol increases chemical synthesis ISO RGD:731284 6480464 HSD17B4 protein results in increased chemical synthesis of Androstenediol CTD PMID:16054388 aniline increases expression ISO RGD:731285 6480464 aniline results in increased expression of HSD17B4 mRNA CTD PMID:22016648 aristolochic acid A decreases expression ISO RGD:731284 6480464 aristolochic acid I results in decreased expression of HSD17B4 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:731284 6480464 Arsenic affects the methylation of HSD17B4 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:731284 6480464 Arsenic affects the methylation of HSD17B4 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:731284 6480464 Arsenic Trioxide results in increased expression of HSD17B4 protein CTD PMID:25419056 atrazine increases expression ISO RGD:731284 6480464 Atrazine results in increased expression of HSD17B4 mRNA CTD PMID:22378314 atrazine decreases expression ISO RGD:731285 6480464 Atrazine results in decreased expression of HSD17B4 mRNA CTD PMID:33463082 benzatropine multiple interactions ISO RGD:731284 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of HSD17B4 protein CTD PMID:34122009 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of HSD17B4 mRNA CTD PMID:19483382 benzofurans increases expression ISO RGD:731284 6480464 Benzofurans results in increased expression of HSD17B4 mRNA CTD PMID:17447562 betamethasone increases expression ISO RGD:731285 6480464 Betamethasone results in increased expression of HSD17B4 mRNA CTD PMID:29901742 bezafibrate increases expression ISO RGD:731285 6480464 Bezafibrate results in increased expression of HSD17B4 mRNA CTD PMID:17118139 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731285 6480464 Diethylhexyl Phthalate results in increased expression of HSD17B4 mRNA CTD PMID:19245819 , PMID:19850644 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSD17B4 mRNA, [bisphenol A co-treated with Estradiol] results in decreased expression of HSD17B4 mRNA CTD PMID:26496021 , PMID:36041667 bisphenol A decreases expression ISO RGD:731284 6480464 bisphenol A results in decreased expression of HSD17B4 protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:731285 6480464 bisphenol A results in decreased expression of HSD17B4 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HSD17B4 mRNA CTD PMID:30816183 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HSD17B4 mRNA CTD PMID:25181051 Bisphenol A diglycidyl ether affects response to substance ISO RGD:731284 6480464 HSD17B4 gene SNP affects the susceptibility to 2, 2-bis(4-glycidyloxyphenyl)propane CTD PMID:25622337 Bisphenol B increases expression ISO RGD:731284 6480464 bisphenol B results in increased expression of HSD17B4 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:731284 6480464 bisphenol F results in increased expression of HSD17B4 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSD17B4 mRNA CTD PMID:36041667 cadmium atom multiple interactions ISO RGD:731284 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSD17B4 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:731284 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSD17B4 mRNA CTD PMID:35301059 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of HSD17B4 mRNA CTD PMID:17293106 carbamazepine affects expression ISO RGD:731284 6480464 Carbamazepine affects the expression of HSD17B4 mRNA CTD PMID:25979313 carboplatin decreases expression EXP 6480464 Carboplatin results in decreased expression of HSD17B4 mRNA CTD PMID:18172885 CGP 52608 multiple interactions ISO RGD:731284 6480464 CGP 52608 promotes the reaction [RORA protein binds to HSD17B4 gene] CTD PMID:28238834 chlorothalonil decreases expression ISO RGD:731285 6480464 tetrachloroisophthalonitrile results in decreased expression of HSD17B4 protein CTD PMID:30586609 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of HSD17B4 mRNA CTD PMID:9209713 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of HSD17B4 mRNA CTD PMID:18172885 cisplatin multiple interactions ISO RGD:731284 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of HSD17B4 mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:731285 6480464 Clobetasol results in increased expression of HSD17B4 mRNA CTD PMID:27462272 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of HSD17B4 mRNA CTD PMID:18246545 , PMID:19483382 clofibrate increases expression ISO RGD:731285 6480464 Clofibrate results in increased expression of HSD17B4 mRNA CTD PMID:17585979 , PMID:23811191 clofibrate multiple interactions ISO RGD:731285 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of HSD17B4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSD17B4 mRNA] CTD PMID:17585979 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of HSD17B4 mRNA CTD PMID:18246545 colforsin daropate hydrochloride increases expression ISO RGD:731284 6480464 Colforsin results in increased expression of HSD17B4 mRNA CTD PMID:16935330 , PMID:22446829 colforsin daropate hydrochloride affects expression ISO RGD:731284 6480464 Colforsin affects the expression of HSD17B4 mRNA CTD PMID:20726872 colforsin daropate hydrochloride multiple interactions ISO RGD:731284 6480464 Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of HSD17B4 mRNA] more ... CTD PMID:16935330 , PMID:20726872 copper atom decreases expression EXP 6480464 Copper deficiency results in decreased expression of HSD17B4 mRNA, Copper results in decreased expression of HSD17B4 mRNA CTD PMID:19821111 , PMID:22465980 copper(0) decreases expression EXP 6480464 Copper deficiency results in decreased expression of HSD17B4 mRNA, Copper results in decreased expression of HSD17B4 mRNA CTD PMID:19821111 , PMID:22465980 copper(II) sulfate decreases expression ISO RGD:731284 6480464 Copper Sulfate results in decreased expression of HSD17B4 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:731285 6480464 Asbestos, Crocidolite results in decreased expression of HSD17B4 mRNA CTD PMID:29279043 Cuprizon multiple interactions ISO RGD:731284 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of HSD17B4 protein CTD PMID:34122009 cyclosporin A decreases expression ISO RGD:731284 6480464 Cyclosporine results in decreased expression of HSD17B4 mRNA CTD PMID:20106945 , PMID:23830897 cyclosporin A decreases expression ISO RGD:731285 6480464 Cyclosporine results in decreased expression of HSD17B4 mRNA CTD PMID:19770486 , PMID:23830897 dehydroepiandrosterone affects metabolic processing ISO RGD:731284 6480464 HSD17B4 protein affects the metabolism of Dehydroepiandrosterone CTD PMID:16054388 dehydroepiandrosterone increases chemical synthesis ISO RGD:731284 6480464 HSD17B4 protein results in increased chemical synthesis of Dehydroepiandrosterone CTD PMID:16054388 dexamethasone increases expression ISO RGD:731285 6480464 Dexamethasone results in increased expression of HSD17B4 mRNA CTD PMID:29901742 diarsenic trioxide increases expression ISO RGD:731284 6480464 Arsenic Trioxide results in increased expression of HSD17B4 protein CTD PMID:25419056 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of HSD17B4 protein CTD PMID:9209713 dicrotophos decreases expression ISO RGD:731284 6480464 dicrotophos results in decreased expression of HSD17B4 mRNA CTD PMID:28302478 diuron increases expression EXP 6480464 Diuron results in increased expression of HSD17B4 mRNA CTD PMID:21551480 doxorubicin increases expression ISO RGD:731285 6480464 Doxorubicin results in increased expression of HSD17B4 mRNA CTD PMID:22016648 doxorubicin decreases expression ISO RGD:731285 6480464 Doxorubicin results in decreased expression of HSD17B4 mRNA CTD PMID:26873546 doxorubicin multiple interactions ISO RGD:731285 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of HSD17B4 mRNA CTD PMID:26873546 entacapone affects binding EXP 6480464 entacapone binds to HSD17B4 protein CTD PMID:19783845 estrone increases chemical synthesis ISO RGD:731284 6480464 HSD17B4 protein results in increased chemical synthesis of Estrone CTD PMID:16054388 estrone affects metabolic processing ISO RGD:731284 6480464 HSD17B4 protein affects the metabolism of Estrone CTD PMID:16054388 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of HSD17B4 protein CTD PMID:23200777 fenofibrate increases expression ISO RGD:731285 6480464 Fenofibrate results in increased expression of HSD17B4 mRNA CTD PMID:17118139 fenofibrate increases expression ISO RGD:731284 6480464 Fenofibrate results in increased expression of HSD17B4 mRNA CTD PMID:25572481 finasteride increases expression EXP 6480464 Finasteride results in increased expression of HSD17B4 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of HSD17B4 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:731285 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HSD17B4 mRNA CTD PMID:22206623 gallic acid decreases expression ISO RGD:731284 6480464 Gallic Acid results in decreased expression of HSD17B4 mRNA CTD PMID:34408198 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of HSD17B4 mRNA, Gemfibrozil results in increased expression of HSD17B4 protein CTD PMID:9209713 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of HSD17B4 mRNA CTD PMID:24136188 haloperidol decreases expression ISO RGD:731284 6480464 Haloperidol results in decreased expression of HSD17B4 protein CTD PMID:34122009 inulin multiple interactions ISO RGD:731285 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of HSD17B4 mRNA CTD PMID:36331819 ivermectin decreases expression ISO RGD:731284 6480464 Ivermectin results in decreased expression of HSD17B4 protein CTD PMID:32959892 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of HSD17B4 mRNA CTD PMID:20080153 ketoconazole multiple interactions ISO RGD:731284 6480464 Ketoconazole promotes the reaction [Colforsin results in increased expression of HSD17B4 mRNA] CTD PMID:16935330 ketoconazole increases expression ISO RGD:731284 6480464 Ketoconazole results in increased expression of HSD17B4 mRNA CTD PMID:16935330 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of HSD17B4 mRNA CTD PMID:19483382 lead(0) decreases expression ISO RGD:731284 6480464 Lead results in decreased expression of HSD17B4 mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:731284 6480464 Lead results in decreased expression of HSD17B4 mRNA CTD PMID:19921347 menadione affects expression ISO RGD:731284 6480464 Vitamin K 3 affects the expression of HSD17B4 mRNA CTD PMID:20044591 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of HSD17B4 mRNA CTD PMID:30467583 methotrexate increases expression ISO RGD:731284 6480464 Methotrexate results in increased expression of HSD17B4 mRNA CTD PMID:17400583 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of HSD17B4 mRNA CTD PMID:12706301 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of HSD17B4 mRNA CTD PMID:21515302 N-methyl-4-phenylpyridinium decreases expression ISO RGD:731285 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of HSD17B4 protein CTD PMID:26558463 NAD zwitterion multiple interactions ISO RGD:731284 6480464 NAD binds to and results in increased activity of HSD17B4 protein CTD PMID:25526675 NAD(+) multiple interactions ISO RGD:731284 6480464 NAD binds to and results in increased activity of HSD17B4 protein CTD PMID:25526675 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of HSD17B4 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:731284 6480464 Nickel results in decreased expression of HSD17B4 mRNA CTD PMID:23195993 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of HSD17B4 mRNA CTD PMID:24136188 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of HSD17B4 mRNA CTD PMID:19483382 ozone multiple interactions ISO RGD:731284 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of HSD17B4 mRNA more ... CTD PMID:32699268 paclitaxel affects response to substance ISO RGD:731284 6480464 HSD17B4 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 paracetamol multiple interactions ISO RGD:731285 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of HSD17B4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSD17B4 mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of HSD17B4 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:731284 6480464 Acetaminophen results in decreased expression of HSD17B4 mRNA CTD PMID:25704631 , PMID:29067470 paracetamol affects expression ISO RGD:731285 6480464 Acetaminophen affects the expression of HSD17B4 mRNA CTD PMID:17562736 pentachlorophenol decreases expression ISO RGD:731284 6480464 Pentachlorophenol results in decreased expression of HSD17B4 mRNA CTD PMID:21296122 perfluoroheptanoic acid increases expression ISO RGD:731284 6480464 perfluoro-n-heptanoic acid results in increased expression of HSD17B4 mRNA CTD PMID:23567314 perfluorohexanesulfonic acid increases expression ISO RGD:731284 6480464 perfluorohexanesulfonic acid results in increased expression of HSD17B4 mRNA CTD PMID:23567314 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of HSD17B4 mRNA CTD PMID:18692542 , PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:731285 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSD17B4 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of HSD17B4 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:731284 6480464 perfluorooctane sulfonic acid results in decreased expression of HSD17B4 mRNA CTD PMID:23074026 perfluorooctane-1-sulfonic acid increases expression ISO RGD:731284 6480464 perfluorooctane sulfonic acid results in increased expression of HSD17B4 mRNA CTD PMID:23567314 perfluorooctane-1-sulfonic acid increases expression ISO RGD:731285 6480464 perfluorooctane sulfonic acid results in increased expression of HSD17B4 mRNA CTD PMID:19429403 , PMID:20936131 perfluorooctanoic acid increases expression ISO RGD:731285 6480464 perfluorooctanoic acid results in increased expression of HSD17B4 mRNA CTD PMID:17681415 more ... perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of HSD17B4 mRNA, perfluorooctanoic acid results in increased expression of HSD17B4 protein CTD PMID:28511854 , PMID:34958885 perfluorooctanoic acid increases expression ISO RGD:731284 6480464 perfluorooctanoic acid results in increased expression of HSD17B4 mRNA CTD PMID:23567314 perfluorooctanoic acid multiple interactions ISO RGD:731285 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of HSD17B4 mRNA] CTD PMID:18467677 , PMID:20936131 phenobarbital decreases expression ISO RGD:731285 6480464 Phenobarbital results in decreased expression of HSD17B4 mRNA CTD PMID:19850644 phenobarbital multiple interactions ISO RGD:731285 6480464 NR1I3 protein promotes the reaction [Phenobarbital results in decreased expression of HSD17B4 mRNA] CTD PMID:19850644 phlorizin decreases expression ISO RGD:731285 6480464 Phlorhizin results in decreased expression of HSD17B4 mRNA CTD PMID:22538082 pirinixic acid multiple interactions ISO RGD:731285 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of HSD17B4 mRNA] more ... CTD PMID:15777286 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of HSD17B4 mRNA, pirinixic acid results in increased expression of HSD17B4 protein CTD PMID:16940010 more ... pirinixic acid increases expression ISO RGD:731285 6480464 pirinixic acid results in increased expression of HSD17B4 mRNA CTD PMID:15375163 more ... pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of HSD17B4 mRNA CTD PMID:19483382 Propiverine affects binding EXP 6480464 propiverine binds to HSD17B4 protein CTD PMID:29273565 quercetin decreases expression ISO RGD:731284 6480464 Quercetin results in decreased expression of HSD17B4 mRNA CTD PMID:21632981 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of HSD17B4 mRNA CTD PMID:16079270 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of HSD17B4 mRNA CTD PMID:18299717 resveratrol increases expression ISO RGD:731285 6480464 resveratrol results in increased expression of HSD17B4 protein CTD PMID:25505154 resveratrol multiple interactions ISO RGD:731284 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of HSD17B4 mRNA CTD PMID:23557933 rotenone increases expression ISO RGD:731285 6480464 Rotenone results in increased expression of HSD17B4 mRNA CTD PMID:22016648 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of HSD17B4 protein CTD PMID:29459688 sodium fluoride decreases expression ISO RGD:731285 6480464 Sodium Fluoride results in decreased expression of HSD17B4 protein CTD PMID:28918527 streptozocin affects expression ISO RGD:731285 6480464 Streptozocin affects the expression of HSD17B4 mRNA CTD PMID:18583417 sulfasalazine increases expression ISO RGD:731285 6480464 Sulfasalazine results in increased expression of HSD17B4 mRNA CTD PMID:22016648 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of HSD17B4 mRNA CTD PMID:20371263 sunitinib decreases expression ISO RGD:731284 6480464 Sunitinib results in decreased expression of HSD17B4 mRNA CTD PMID:31533062 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of HSD17B4 mRNA CTD PMID:21515302 testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of HSD17B4 mRNA CTD PMID:25603467 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of HSD17B4 mRNA CTD PMID:16239168 tetrachloromethane decreases expression ISO RGD:731285 6480464 Carbon Tetrachloride results in decreased expression of HSD17B4 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HSD17B4 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of HSD17B4 mRNA CTD PMID:31150632 tetracycline decreases expression ISO RGD:731285 6480464 Tetracycline results in decreased expression of HSD17B4 mRNA CTD PMID:24489787 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of HSD17B4 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of HSD17B4 mRNA CTD PMID:26222700 , PMID:34492290 tolcapone affects binding EXP 6480464 tolcapone binds to HSD17B4 protein CTD PMID:19783845 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of HSD17B4 mRNA CTD PMID:19448997 troglitazone increases expression ISO RGD:731285 6480464 troglitazone results in increased expression of HSD17B4 mRNA CTD PMID:12732648 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of HSD17B4 mRNA CTD PMID:21515302 urethane decreases expression ISO RGD:731284 6480464 Urethane results in decreased expression of HSD17B4 mRNA CTD PMID:28818685 valproic acid multiple interactions ISO RGD:731284 6480464 Valproic Acid affects the reaction [Colforsin affects the expression of HSD17B4 mRNA] CTD PMID:20726872 valproic acid affects expression ISO RGD:731284 6480464 Valproic Acid affects the expression of HSD17B4 mRNA CTD PMID:25979313 zearalenone decreases expression ISO RGD:731285 6480464 Zearalenone results in decreased expression of HSD17B4 protein CTD PMID:31419471 zoledronic acid decreases expression ISO RGD:731285 6480464 zoledronic acid results in decreased expression of HSD17B4 mRNA CTD PMID:28871336